PMID: 2498945Jan 1, 1989Paper

A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites

Psychopharmacology
B M CohenC Waternaux

Abstract

Fifty-three patients in an acute episode or exacerbation of psychosis were given thioridazine 200 or 400 mg daily for 2 weeks. Thioridazine and its active metabolites, mesoridazine and sulforidazine, were estimated in plasma by high performance liquid chromatography (HPLC) and radioreceptor assay (RRA). One week after institution of treatment, plasma concentrations of drug were stable in the morning 12h after dosing. Drug levels varied widely between patients, but in all patients the relative level of thioridazine to mesoridazine was about one half and thioridazine to sulforidazine was about two fold. Estimates of neuroleptic activity by RRA and the weighted sum of thioridazine, mesoridazine and sulforidazine by HPLC were very similar. Plasma concentration of parent compound, metabolites, or the sum of active substances as estimated by HPLC or RRA, showed only modest correlations (rs = 0.10-0.22, all NS) to the degree of improvement as measured by change on the Brief Psychiatric Rating Scale. Significant correlations were observed between plasma concentrations of drug and side effects, including dry mouth, blurred vision, or total rating on the Somatic Symptoms Scale. Even patients receiving the lowest dose and achieving the lo...Continue Reading

References

Jan 3, 1977·European Journal of Clinical Pharmacology·F A Vanderheeren, R G Muusze
Sep 1, 1978·Archives of General Psychiatry·P R May, T Van Putten
May 1, 1985·The Journal of Clinical Psychiatry·G M Simpson, K Yadalam
Oct 1, 1985·Journal of Clinical Psychopharmacology·T B Cooper
Oct 1, 1985·Journal of Clinical Psychopharmacology·S H Curry
Jan 1, 1986·Psychosomatics·B M Cohen, J F Lipinski
Jan 1, 1987·Schizophrenia Bulletin·J M Kane
Jan 1, 1988·Archives of General Psychiatry·R J BaldessariniM H Teicher
Feb 1, 1987·Journal of Clinical Psychopharmacology·J Volavka, T B Cooper
Jun 1, 1986·Journal of Clinical Psychopharmacology·R I Shader, D J Greenblatt
Jun 1, 1986·Journal of Clinical Psychopharmacology·J P McEvoyR Farr
Nov 1, 1972·Clinical Pharmacology and Therapeutics·G SakalisM H Lader
Jan 1, 1980·Psychopharmacology·B M CohenR I Altesman
Oct 1, 1983·Archives of General Psychiatry·G A KeepersD E Casey
Jun 1, 1984·The American Journal of Psychiatry·R J BaldessariniP Cotton
Jan 1, 1983·Psychopharmacology·M L MavroidisD L Garver
Jan 1, 1984·European Archives of Psychiatry and Neurological Sciences·P LinkowskiJ Mendlewicz
Jun 1, 1984·Journal of Clinical Psychopharmacology·D L GarverM L Mavroidis
Jan 1, 1982·Acta Pharmacologica Et Toxicologica·M LinnoilaR J Wyatt
Feb 1, 1981·Archives of General Psychiatry·P R MayW J Dixon
Oct 1, 1981·The American Journal of Psychiatry·M WahbaA Meadow
Jul 1, 1980·Neuropharmacology·B M CohenR J Baldessarini

❮ Previous
Next ❯

Citations

Jun 1, 1993·Journal of Pharmaceutical and Biomedical Analysis·C B EapP Baumann
Jun 7, 2005·Forensic Science International : Synergy·Kabrena E RoddaOlaf H Drummer
Jan 13, 2004·Clinical Pharmacokinetics·Candace S BrownSamantha F Eichner
Feb 1, 1994·Forensic Science International : Synergy·S A JortaniA Poklis
Apr 27, 2007·Clinical Pharmacology and Therapeutics·R H K ThanacoodyS H L Thomas
Sep 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·N A Buckley, P Sanders
Apr 14, 2019·Cellular Oncology (Dordrecht)·Guillem RamisPriam Villalonga
Feb 22, 2018·Clinical Pharmacokinetics·Nithya SrinivasAngela D M Kashuba
Nov 8, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jacek WójcikowskiWładysława A Daniel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here